FIBRISTAL (Ulipristal acetate (5mg))

Fibristal Tablet is prescribed for the management of uterine fibroids, which are benign tumors located in the uterus, specifically for women who are in their premenopausal stage and are either not candidates for surgery or have not had a favorable response to surgical treatments. This medication aims to alleviate various symptoms associated with fibroids, such as heavy vaginal bleeding, extended menstrual cycles, and discomfort in the lower back. Patients are advised to adhere strictly to the dosage and duration outlined by their healthcare provider, and the medication can be ingested regardless of meal times; however, consistency in timing is recommended to enhance its effectiveness. It is critical to understand that Fibristal Tablet can diminish the efficacy of contraceptive methods, therefore, it is essential to employ alternative means of birth control to prevent unintended pregnancies. Typically, menstruation may cease within ten days of commencing the treatment, but if heavy bleeding persists, it is important to consult a healthcare professional. While the absence of menstruation may be noted during treatment, normal menstrual cycles generally resume within four weeks following the completion of the course. Patients are encouraged to inform their doctor about any history of liver issues or severe asthma prior to starting this medication, as routine blood tests may be necessary to assess liver function during the course of treatment. Additionally, it is vital to disclose all other medications being taken to avoid potential interactions.